Challenges and safety of beta-lactam desensitization during extracorporeal membrane oxygenation

Ann Allergy Asthma Immunol. 2019 Jun;122(6):661-663. doi: 10.1016/j.anai.2019.03.005. Epub 2019 Mar 13.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Acetates / therapeutic use
  • Allergens / immunology*
  • Anaphylaxis / etiology
  • Anaphylaxis / prevention & control*
  • Anti-Infective Agents / therapeutic use
  • Antibiotic Prophylaxis
  • Cetirizine / therapeutic use
  • Cyclopropanes
  • Cystic Fibrosis / complications
  • Cystic Fibrosis / therapy*
  • Desensitization, Immunologic / methods*
  • Drug Hypersensitivity / complications
  • Drug Hypersensitivity / drug therapy*
  • Extracorporeal Membrane Oxygenation / methods*
  • Famotidine / therapeutic use
  • Female
  • Humans
  • Immune Tolerance
  • Male
  • Quinolines / therapeutic use
  • Respiratory Insufficiency
  • Sulfides
  • beta-Lactams / immunology*

Substances

  • Acetates
  • Allergens
  • Anti-Infective Agents
  • Cyclopropanes
  • Quinolines
  • Sulfides
  • beta-Lactams
  • Famotidine
  • montelukast
  • Cetirizine